𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Patterns of α-l-fucosidase in acute myeloid leukemia cells. Comparison with promyelocytic HL-60 cell line

✍ Scribed by Isabelle Dosbaa; Marguerite Bernard; Marie-José Foglietti; François Percheron; Carla Emiliani


Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
421 KB
Volume
236
Category
Article
ISSN
0008-6215

No coin nor oath required. For personal study only.

✦ Synopsis


Changes were observed in alpha-L-fucosidase forms in cells from acute myelocytic leukemias (AML). Total alpha-L-fucosidase activity was not significantly different for normal granulocytes and leukemic cells, but enzymic profiles obtained by chromatofocusing are quite different. In granulocyte profile, two main peaks are present (B and more acidic A) which were eluted at pH 5.2 with a shoulder at pH 4.6. In AMLs the B form is present but weakly expressed, whereas the more acidic forms are the major ones. This pattern may be related either to the malignancy character or to the stage at which the differentiation is stopped. Experiments on an HL-60 cell line (promyelocytic cells corresponding to the AML 3 type) showed that differentiation induced by dimethyl sulfoxide leads to the appearance of the B form present in normal mature cells. Thus the repartition of the enzyme forms seems to be related to the stage of differentiation of the myelocytic cells.


📜 SIMILAR VOLUMES


Resistance to 1,25D-induced differentiat
✍ Edward Garay; Robert Donnelly; Xuening Wang; George P. Studzinski 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB

## Abstract The anti‐neoplastic effects of 1,25‐dihydroxyvitamin D~3~ (1,25D) are well documented in numerous tumor cell systems and animal models of cancer. However, despite this pre‐clinical success, the clinical use of 1,25D is currently impeded by the dose‐limiting hypercalcemia, and the risk o

Establishment of the acute myeloid leuke
✍ Hiroya Asou; Adrian F. Gombart; Seisho Takeuchi; Hideo Tanaka; Maki Tanioka; Hir 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

## Abstract A myeloid leukemia cell line designated Kasumi‐6 was established from the bone marrow cells of an individual with acute myeloid leukemia, subtype M2. Both the original leukemic cells and the Kasumi‐6 cell line harbor a hemizygous point mutation in the gene encoding the CCAAT/enhancer bi